Narrow search
Showing 1 - 10 of 21
Cover Image
How US antitrust can go astray : the brand name prescription drug litigation
Scherer, Frederic M. - In: Wettbewerbspolitik im Spannungsfeld nationaler und …, (pp. 143-163). 1997
Persistent link: https://www.econbiz.de/10001320896
Cover Image
Pharmaceutical innovation
Scherer, Frederic M. (contributor) - 2007
Persistent link: https://www.econbiz.de/10003435595
Cover Image
Markets and uncertainty in pharmaceutical development
Scherer, Frederic M. (contributor) - 2007
Persistent link: https://www.econbiz.de/10003621527
Cover Image
Uncertainty and choice : the challenges of pharmaceutical efficacy, safety, and cost
Scherer, Frederic M. - In: Managerial and decision economics : MDE ; the … 28 (2007) 4/5, pp. 267-283
Persistent link: https://www.econbiz.de/10003543621
Cover Image
Pharmaceutical innovation
Scherer, Frederic M. - 2010
Persistent link: https://www.econbiz.de/10003981178
Cover Image
R&D costs and productivity in biopharmaceuticals
Scherer, Frederic M. - 2011
Persistent link: https://www.econbiz.de/10009487480
Cover Image
Dynamics and regulation of the Asian pharmaceutical industry : a critical review
Scherer, Frederic M. (contributor) - 2008
Persistent link: https://www.econbiz.de/10003749075
Cover Image
How US antitrust can go astray : the brand name prescription drug litigation
Scherer, Frederic M. - In: Competition policy, domestic and international, (pp. 143-160). 2000
Persistent link: https://www.econbiz.de/10003047170
Cover Image
The pharmaceutical industry
Scherer, Frederic M. - 2000
Persistent link: https://www.econbiz.de/10001573650
Cover Image
Pricing, profits, and technological progress in the pharmaceutical industry
Scherer, Frederic M. - In: The journal of economic perspectives : EP ; a journal … 7 (1993) 3, pp. 97-115
Persistent link: https://www.econbiz.de/10001148846